Trials / Completed
CompletedNCT02300532
Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 561 (actual)
- Sponsor
- Eisai Co., Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Post-marketing surveillance to investigate the clinical safety and effectiveness in patients of all implantation of Gliadel with malignant glioma in the actual medical setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention |
Timeline
- Start date
- 2013-01-10
- Primary completion
- 2014-07-10
- Completion
- 2015-03-24
- First posted
- 2014-11-25
- Last updated
- 2017-02-27
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02300532. Inclusion in this directory is not an endorsement.